SmartGuide Disposable Guides and Grids
UC-CARE , Ltd. · Decision date Jul 30, 2026
What did the FDA decide?
FDA records K260161 as a 510(k) premarket notification, with a decision dated Jul 30, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Jul 30, 2026
Regulatory record facts
- Identifier
- K260161
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- UC-CARE , Ltd.
- Product code
- ITX
- Decision code
- SESE
- Decision date
- Jul 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Transducer, Ultrasonic, Diagnostic.
- Applicant
- UC-CARE , Ltd.
- Product code
- ITX
- FDA device class
- 2
FDA decision timeline
K260161 received
Application receipt date recorded by FDA.
K260161 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code ITX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| CIVCO Medical Instruments Co., Inc. | 510(k) clearance | Sep 24, 2026 | FDA | |
BA-004CCK261170 | Fujifilm Corporation | 510(k) clearance | Aug 12, 2026 | FDA |
| EM-TECH Solutions, Inc. | 510(k) clearance | Aug 10, 2026 | FDA | |
ND Needle Guidance SystemK262474 | Accurate Access, LLC | 510(k) clearance | Jul 27, 2026 | FDA |
Accuro 3S Needle Guide KitK261014 | Rivanna Medical, Inc. | 510(k) clearance | Jul 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
UC-CARE , Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Yokneam
Sources and methodology
- Original FDA record: K260161
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



